Prodrug activation gene therapy and external beam irradiation in the treatment of prostate cancer
- 1 December 1999
- Vol. 54 (6) , 1098-1104
- https://doi.org/10.1016/s0090-4295(99)00295-2
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Update on the treatment of prostate cancer with external beam irradiationThe Prostate, 1998
- External beam radiotherapy for stage T1/T2 prostate cancer: how does it stack up?Urology, 1998
- Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Phase II trial of external beam radiation with etanidazole (SR 2508) for the treatment of locally advanced prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Radical Radiation Therapy in the Management of Prostatic Adenocarcinoma: The Initial Prostate Specific Antigen Value as a Predictor of Treatment OutcomeJournal of Urology, 1994
- Platinum drug delivery and radiation for locally advanced prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1994
- The effect of local control on metastatic dissemination in carcinoma of the prostate: Long-term results in patients treated with 1251 implantationInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Phase II Radiation Therapy Oncology Group Study of Hormonal Cytoreduction with Flutamide and Zoladex in Locally Advanced Carcinoma of the Prostate Treated with Definitive RadiotherapyAmerican Journal of Clinical Oncology, 1990
- Morbidity and Mortality of Local Failure after Definitive Therapy for Prostate CancerJournal of Urology, 1989
- Effect of local tumor control on distant metastasis and survival in prostatic adenocarcinomaUrology, 1987